We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ALLR market cap is 9.27M. The company's latest EPS is USD -3.3042 and P/E is -0.46.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.56M | -6.75M | -3.66M | -4.17M | -4.43M |
| Net Income | -6.68M | -3.1M | -3.36M | -9.79M | -5.55M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -9.23M | -26.56M | -34.46M | -17.13M |
| Net Income | -5.06M | -26.65M | -21.05M | -20.42M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 18.13M | 14.54M | 12.7M | 13.43M | 13.88M |
| Total Liabilities | 14.63M | 12.65M | 13.04M | 14.15M | 17.25M |
| Total Equity | 1.45M | -113k | -3.1M | -723k | -3.38M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 33.4M | 49.63M | 14.54M | 11.86M |
| Total Liabilities | 6.55M | 30.85M | 12.65M | 14.61M |
| Total Equity | 26.85M | 18.15M | -113k | -2.75M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -14.37M | -16.82M | -3.2M | -5.7M | -11.07M |
| Investing | 809k | 791k | N/A | N/A | N/A |
| Financing | -2.31M | -1.31M | 1.16M | 4.02M | 10.47M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.25M | -15.05M | -16.82M | -12.75M |
| Investing | -3k | 1M | 791k | N/A |
| Financing | 6.03M | 33.82M | -1.31M | 11M |
| Market Cap | 9.27M |
| Price to Earnings Ratio | -0.46 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 56.13 |
| Price to Book Ratio | -3.39 |
| Dividend Yield | - |
| Shares Outstanding | 6.18M |
| Average Volume (1 week) | 886.24k |
| Average Volume (1 Month) | 2.49M |
| 52 Week Change | -99.99% |
| 52 Week High | 17,699.20 |
| 52 Week Low | 1.27 |
| Spread (Intraday) | 0.05 (3.31%) |
| Company Name | Allarity Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.allarity.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
